During the eight decades which have elapsed since Hurler's syndrome was first described, many hypotheses have been formed concerning the nature of the basic biochemical defects which may underly the clinical manifestations present in this and the other mucopolysaccharidoses. Washington (1937) proposed that the basic fault was a defect in lipid metabolism since the physical changes, such as hepatosplenomegaly, were reminiscent of those occurring in the lipidoses. Others suggested that the storage material might be glycogen or glycoprotein, inferring that there was some error in carbohydrate metabolism. On the other hand, the skin changes and the joint contractures which occur in Hurler's syndrome led Straus, Mellis, and Reiser (1947) to suggest that a dystrophy of collagen was involved. Brante (1952) stated that there was a disturbance of an enzyme concerned with the metabolism of the mucopolysaccharides or some of their components, or an interference with the binding of the mucopolysaccharide to the protein moiety. Uzman (1955) held a similar view and suggested that the genetic defect is in the synthesis of the structural polysaccharides. The discovery by Dorfman (1957) of chondroitin sulphate B (now known as dermatan sulphate) and heparan sulphate in the urine and tissues of patients with Hurler's disease substantiated to a great extent the view that this is a mucopolysaccharidosis. This may be an over-simplification, however, and this group of diseases may be accompanied by a disorder of lipid metabolism, even though this may be confined to the brain.
It must be emphasised, however, that the true nature of the material excreted in the rnucopolysaccharidoses is still not known. The sulphated mucopolysaccharides may be of varying molecular size and the extent to which they are combined with protein is still uncertain. These facts must be borne in mind as the analytical and patho-physiological problems are approached, but even before the nature of the storage material has been established the important question of how and why the material accumulates can be considered. Three possibilities seem to exist; namely, that there is over-production of the material, that there is faulty breakdown of the material, or that there is faulty removal of the material. In order to decide between these possibilities, it is necessary to examine the metabolic Paper read at National Meeting, London, September, 1968. pathways involved in the biosynthesis and degradation of these compounds: possible blocks in these pathways may then be postulated and finally experiments designed to test them.
It is suggested that biosynthesis occurs in the following stages. The protein part of the complete molecule is synthesised as usual on the ribosome. Meanwhile, the polysaccharide chain is assembled and then sulphated. When this has been accomplished, the two are brought together on the microsomal membrane where the sugar components are attached to the protein by a glycosyl transfer reaction. This process is similar to that followed in the biosynthesis of glycoproteins but Telser, Robinson, and Dorfman (1965) have demonstrated the same pathway for chondroitin sulphate.
Heparin, a sulphated polymer of D-glucuronic acid and D-galactosamine, is produced in mast cells and it has been demonstrated that microsomal preparations from these cells of the mouse will incorporate equimolar amounts of D-glucuronic acid and N-acetyl galactosamine, via a UDP derivative, into a polysaccharide which seems to be a precursor of heparin (Silbert, 1964) . The involvement of UDP in such a system is suggested by the fact that when tritiated UDP-sugar was used, the hyaluronic acid formed contained the radioactive label.
The mechanism by which the monosaccharide units are caused to alternate in the polysaccharide chain has not yet been elucidated. However, Markowitz, Cifonelli, and Dorfman (1959) have suggested that the enzyme responsible for synthesis possesses two sites of attachment, one for the uronic acid and one for the N-acetyl hexosamine and that when one is occupied, for example by uronic acid, the partially synthesised chain will not be released until the other site is occupied by a hexosamine and the condensation of this on to the chain has been initiated. When this has occurred the other site is free to accept a further molecule of uronic acid.
The sulphation mechanism is said to involve 'active sulphate', 3-phosphoadenosine 5 /-phosphosulphate (pAPS) and Straminger (1959, 1960) have shown that sulphate is transferred. from this to the N-acetyl galactosamine residues of the polysaccharide. They found this surprising because UDP N-acetyl D-galactosamine sulphate itself was present in the tissue and it might have been expected that the sulphated galactosamine would be 49 transferred as a unit.
The enzymes involved in the degradation of the mucopolysaccharides include: firstly the enzyme splitting the protein-polysaccharide link, secondly, the hexosaminidases and glucuronidases, and thirdly, the galactosidases.
Evidence for the enzymic division of the protempolysaccharide link in cartilage is provided by the fact that whilst a complex containing chondroitin sulphate and protein can be extracted from cartilage, no similar complex can be obtained from bone. It is suggested that some autolytic activity must occur in cartilage before this can be calcified to form bone and Dziewiatkowski, Tourtellotte and Campo (1967) have isolated and characterised such an enzyme from calf cartilage. Furthermore, when rudimentary bone is incubated at pH 3 to 5 in media containing water-soluble extracts from similar rudimentary bone tissue, hexosamine and protein components can be shown to diffuse into the surrounding medium.
The mucopolysaccharases have been extensively studied, but most of the work has been with bacterial systems and the findings may not be directly applicable to mammalian tissue. Walker (1%1) classified the mucopolysaccharases according to the mechanisms involved in their reactions. His classes were: the endohexosaminidases, involved in transglycosylation, the transfer of hexose residues from one component to another; the hexosaminidases which participate in elimination reactions and the endoglucuronidases which are involved in hydrolysis reactions. The end-products from these reactions are oligosaccharides of two to four residues, which may then be broken down by N-acetyl {J-hexosaminidases, {J-galactosidase and other hexosidases and {J-glucuronidases. It is therefore clear that there are many points at which errors in the metabolism of the mucopolysaccharides can occur.
Several suggestions have been made concerning the nature of the lesion in the mucopolysaccharidoses but Hers has reported verbally in recent lectures that he has demonstrated in Hurler's syndrome a marked diminution of ,8-galactosidase and he and others have obtained evidence that some similar diseases may be due to a deficiency of a-mannosidase and a fucosidase (van Hoof and Hers, 1968; Durand et al., 1968) . It is also possible that this group of diseases could arise from a fault in the protein part of the complex. This could be at the site of combination of the protein with the polysaccharide or it may occur at the level of coding for the protein so that either an abnormal protein is produced or the normal protein is produced in excess due to a failure of a repressor gene. Until it is known which are the rate limiting steps in the biosynthesis it will not be possible to differentiate between these possibilities.
Classification of the Mucopolysaccharidoses
The mucopolysaccharidoses have been classified by McKusick (1966) into six categories. These are listed in Table I . While this gives a fairly simple outline of the situation, recent work has shown that this may be more complex. For example, it has been suggested that excretion of dermatan sulphate may occur in the Sanfilippo syndrome in addition to heparatin sulphate. Also, it has been suggested that the ratio of dermatan sulphate and heparatin sulphate excreted in cases of Hurler's disease and Hunter's disease is different (Terry and Linker, 1964) , although several unpublished observations have not lent support to this.
Other mucopolysaccharidoses have also been described. Dyggve, Melchior, and Clausen (1962) have described the Morquio-Ullrich syndrome where the radiological and clinical changes resemble those in Morquio's disease but there is severe mental retardation, and the urine contains dermatan sulphate accompanied by keratan sulphate. Rallo and Infante (1968) have discussed the possibility that progressive myoclonus epilepsy is another type of mucopolysaccharidosis. van Hoof and Hers (1968) have described a condition in which there is an accumulation of fucose derivatives and proposed the name mucopolysaccharidosis F for this disease.
The Determination of Urinary Mucopolysaccharides
The principle by which the mucopolysaccharides which occur in the urine normally or in pathological conditions are separately determined consists of their initial extraction from dialysed urine by a column of Ecteola cellulose, followed by the successive elution of non-sulphated and sulphated fractions (Wessler, 1967) . This technique is preferable to those which precipitate the mucopolysaccharides with quaternary ammonium salts since it is likely that with this treatment, some keratan sulphate, which exists partially in a low molecular weight state, may remain in solution whereas even low molecular weight keratan sulphate will bind to the anion exchanger, Ecteola cellulose. The sulphated fraction is then dialysed against water, applied to a Dowex 1 X 2 column and the several mucopolysaccharides are eluted with sodium chloride solutions of different molarities (Schiller, Slover, and Dorfman, 1961) . The resulting fractions are then analysed for uronic acid by the carbazole method of Dische (1947) as modified by Bitter and Muir (1962) . and for neutral sugar by the anthrone method of Roe (1955) . In order to check the purity of the column effluents, cellulose acetate electrophoresis was performed on the fractions. Separation 50 ml. of a 24-hour urine collection is filtered and dialysed in 24/32 in. Visking tubing at 4°C against repeated changes of distilled water for a period of 3 days. It is possible that after further study, this time may be reduced.
A 5 cm. x 0.9 em. column of Ecteola cellulose is prepared in the hydroxide form by suspending in water and decanting the fines, suspending in 0.5 N HCI, washing to pH 4-5, then immersing in 0.5 N NaOH and washing to pH 7. A suspension of the cellulose in water is then made and the column poured. A useful account of this process is given in the Whatman Technical Bulletin C 5, pp.28-29.
The dialysed urine is applied to the column and this is then washed with 100 ml. of 0.01 M HCl. Non-sulphated glycosamino-glycurans are eluted with 10 ml, of 3 M NaCl. This fraction is then dialysed against repeated changes of distilled water at 4°C for 3 days and then applied to a 40 x 1 em. column of Dowex AG-! x 2 (20Q-400 mesh) in the chloride form. The Dowex column is then washed with water and the mucopolysaccharides are successively eluted with sodium chloride solutions of molarities increasing from 0. 
RESULTS
Urine from 10 patients who were thought to have one of the several types of mucopolysaccharidoses has been examined by the methods described. The results obtained gave an indication of the type of mucopolysaccharidosis present, and three typical cases are shown in Figs. 1-3 dialysis against running tap water and were concentrated to one-fifth of their original volume by dialysis for several hours (usually 4 to 6) against a 30% solution of Carbowax (polyethylene glycol). Cellulose acetate strips (10 x 2.5 cm.) were allowed to equilibrate in the sodium barbiturate: acetate buffer, pH 9.2, as recommended, for 1 hour. About 40 iLl. of concentrated sample was applied to .~ch strip, and about 20 iLl. of a standard contalD!~g hyaluronic acid, heparan sulphate and chondroitin sulphates (kindly prepared and given to us by Dr. Manley) was run alongside. The strips were run at 15 v.ks». for 30 minutes, and washed in running tap water for a further 30 minutes. 
Identification offractions
Whilst the chemical tests provide a good indication of the clinical constituents of materials eluted from the column, they do not provide conclusive evidence for the existence of anyone mucopolysaccharide in any fraction. Each fraction was therefore studied using a cellulose acetate electrophoresis technique similar to that of Manley and Hawksworth (1966) . The fractions were desalted by overnight
Analysis offractions
Uronic acids were determined by the carbazole method of Dische as modified by Bitter and Muir. Materials :-0.025 M sodium tetraborate decahydrate in sulphuric acid (S.G. 1.84). 0.125% carbazole in absolute methanol. Glucuronolactone standard, 2 mg./100 ml, in saturated benzoic acid. Method:-5 ml, of the acid reagent is dispensed into 10 ml, glass stoppered tubes and cooled to -10 0 e in an ice-salt bath. While still in the bath 1 ml, of water, standard or test solution is layered on top of the acid and then gradually mixed with a glass rod, avoiding any increase in temperature. The tubes are then heated in a boiling distilled water bath for 10 minutes, cooled, and the optical density of the solution is measured at 530 ffiIL. 0.2 ml. of carbazole reagent is then added, the tubes shaken, and returned to the boiling water bath for a further 15 minutes when a pink colour develops. The optical densities of the solutions are measured at 530 miL. The first optical density is subtracted from the second in order to compensate for possible charring. A disadvantage of this method is that the presence of any oxidants may result in a green colour instead of the expected pink. For this reason, a distilled water bath is used. Neutral sugars are estimated by the anthrone method of Roe. Materials :-500 mg. anthrone and 10 mg. thiourea dissolved in 500 ml, of 66 % sulphuric acid. Standard galactose solution, 100 mg./100 mI. in saturated benzoic acid. Method.-o.s mI. water, standard or test solution is added to 5 ml. of anthrone reagent and mixed with a glass rod. The tubes are equilibrated in a water bath at room temperature for 5 minutes and then transferred to a boiling water bath for 15 minutes. They are then cooled and after 30 minutes the optical densities of the solutions are measured at 660 miL. Permanganate added to the water bath minimises the effect of light on the reaction. Figure 1 (patient T.W.) shows that increased amounts of heparan sulphate (37.7 mg. uronic acid /24 hour) and dermatan sulphate (15.1 mg. uronic acid/24 hour) are excreted by this child. Cellulose acetate electrophoresis was performed, both on the urine, concentrated some five times, and on the fractions collected from the elution from the Dowex column. Electrophoresis of the concentrated urine showed the presence of both dermatan sulphate and heparan sulphate, and that on the column effluent showed that the 1.25 M sodium chloride fraction contained heparan sulphate, accompanied by a slower moving band which may be hyaluronic acid, carried over from the 0.5 M fraction. Electrophoresis of the 2.0 M fraction showed the presence of dermatan sulphate, however, it was evident that the components eluted by anyone molarity of sodium chloride were not pure and that there was some carry-over from the previous fraction. and a slightly increased amount of dermatan sulphate (0.87 mg. uronic acid/24 hour). From this pattern and reference to the Table, a diagnosis of Hurler's syndrome might be expected. Clinically, however, this child resembled most closely the Sanfilippo syndrome. This has been observed in at least two cases of the Sanfilippo syndrome and previous statements that only heparan sulphate is excreted in this condition may have to be modified. Figure 3 (patient C.C.) shows elevated amounts of dermatan sulphate (3.08 mg. uronic acid/24 hour) and keratan sulphate. The identity of the dermatan sulphate was confirmed by cellulose acetate electrophoresis. Unfortunately, it is not possible to identify keratan sulphate on cellulose acetate electrophoresis by the method described. The findings agree with the clinical diagnosis of Morquio-Ullrich syndrome.
CoNCLUSION
The results show that the technique is useful for the separation of urinary mucopolysaccharides, and that such a technique provides evidence for the diagnosis of any particular mucopolysaccharidosis. However, cellulose acetate electrophoresis shows that the separation achieved is not absolute and because of the likelihood of carry-over from one fraction to the next, errors may occur. Nevertheless, it seems that the method as described gives a useful indication of the mucopolysaccharides present in urine, and further work on the separation technique may result in clearer separations. It should be borne in mind that this type of technique alone will not provide the answers to the many questions at present arising in this field. With the development of the enzymological aspects of the problem, we shall no doubt see a clearer picture of the mucopolysaccharidoses and the related diseases.
Several paediatricians in our own and other hospitals have referred cases to us and we are grateful to them for the opportunity to study this rare material.
